Add BrightSurf on Google Email

Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy

A study found APBIb use increased from 0.4% to 6.6% between 2000 and 2007, with wide regional disparities and racial/ethnic differences in utilization. The authors suggest unwarranted variation in practice may be present, highlighting the need for further research on APBI effectiveness.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateDec 16, 2011

Extreme cold good for exercise recovery

Whole-body cryotherapy outperforms far-infrared radiation and no treatment in enhancing post-exercise recovery for well-trained runners. Three cryotherapy sessions over 48 hours accelerated recovery more than other methods.

SourcePLOS·JournalPLOS ONE·DateDec 7, 2011

Higher doses of radiation in fewer treatments proved safe, effective for low-risk prostate cancer

A multicenter clinical trial found stereotactic body radiation therapy (SBRT) to be an effective treatment option for patients with localized prostate cancer, delivering results in just five 30-minute sessions. The study's findings suggest that higher doses of radiation are safe and can lead to improved outcomes.

SourceUT Southwestern Medical Center·JournalJournal of Clinical Oncology·DateJun 2, 2011

Use of costly breast cancer therapy strongly influenced by reimbursement policy

A study found that Medicare reimbursement policy significantly affects the use of costly breast cancer therapy, including intensity-modulated radiation therapy (IMRT). The analysis showed a sharp increase in IMRT usage and costs between 2001 and 2005, with billing rates varying by region and treatment setting.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateApr 28, 2011

ASTRO publishes evidence-based guideline for thoracic radiotherapy

The American Society for Radiation Oncology (ASTRO) has developed a guideline for palliative thoracic radiation therapy to treat advanced lung cancer. The guideline recommends various regimens of thoracic external beam radiation therapy as effective for symptom palliation, but not endobronchial brachytherapy or concurrent chemotherapy.

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·DateApr 27, 2011

Soy increases effectiveness of radiation at killing lung cancer, Wayne State study shows

A Wayne State University study found that soy isoflavones can sensitize cancer cells to radiation while protecting normal tissue. The study demonstrated that soy isoflavones can block DNA repair mechanisms in cancer cells, leading to increased killing of lung cancer cells by radiation

Soy increases radiation's ability to kill lung cancer cells, study shows

A recent study published in the Journal of Thoracic Oncology found that soy isoflavones can sensitize cancer cells to radiation, increasing killing efficiency while protecting normal lung tissue from damage. Researchers used a soy mixture consisting of genistein, daidzein and glycitein to demonstrate this effect.

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateApr 1, 2011